White background

Vernacare issues voluntary cosmetic product recall

Posted On April 21st, 2022

Vernacare issues voluntary recall across all ‘in date’ cosmetic products as part of an ongoing Pseudomonas investigation. 

Following confirmed detection of Pseudomonas Aeruginosa in a limited number of products, Vernacare have today issued a voluntary recall across all cosmetic goods manufactured at its Lancashire facility and have ceased production until the root cause is identified.

To support the investigation, Vernacare undertook repeat microbial testing on a range of product lots under review by the Norwegian authorities. Unfortunately, the results of the independent testing identified that, despite rigorous testing before release, Pseudomonas Aeruginosa was present in some products.

As a result of the above findings, Vernacare have launched a full and thorough investigation alongside EU Responsible Person (MSL Solution Providers) to identify the root cause of the contamination. The investigation is very much ongoing, with all parts of our manufacturing process, incoming raw material components and product handing under intensive review. During this investigation period, cosmetic production at our Lancashire facility has been temporarily paused.

The root cause has yet to be identified and because of this, the decision has been taken, as a precautionary measure, to issue a full voluntary recall on all ‘in date’ cosmetic products manufactured at the affected facility. This decision has been supported by the Irish Health Products Regulatory Authority.

Whilst Vernacare are fully aware of the implications of halting production and withdrawing mass stock from the healthcare market, the decision has been taken solely in the interest of patients and residents being cared for using these hygiene products. Patient safety remains our utmost priority and until corrective and preventative action can be taken, our focus is firmly on eliminating all potential risk as quickly as possible.

"Although only a limited number of products lots are believed to be impacted, until our internal investigation has been completed, and root cause identified, we believe a full recall is the best course of action to limit any risk for vulnerable patients using these products."

Rachel Downham Business Unit Director, Vernacare

As such, recall notices have been issued to Vernacare’s global distribution network, covering the following product brands:

• Oasis Bedbath – Perfumed

• Oasis Bedbath – Unperfumed

• Oasis Maceratable Bedbath – Perfumed

• Oasis Maceratable Bedbath - Unperfumed

• Oasis Shampoo Cap - Unperfumed

• Oasis Shampoo Cap - Perfumed

• Oasis Washmitt - Unperfumed

• Oasis Washmitt - Perfumed

• Conti Flushable Skin Cleansing Wet Wipes

• Conti Continence Care Skin Cleansing Wipes

• Conti Patient Cleansing Wet Wipes

• Conti Skin Cleansing Wet Wipes

• Conti Continence Care 3% Dimethicone Barrier Cloth

• Senset Skin Cleansing Wipes

If you have supplied, or have been supplied with, an in-date batch of the products listed, please quarantine as soon as possible and contact Vernacare or your Distributor for information on next steps.

Vernacare remain committed to moving the internal investigation forward as quickly as possible to limit disruption to supply, whilst ensuring the regulatory authorities and our valued partners have the information they require too.

Please direct any queries surrounding this investigation or product recall notifications to [email protected].

Conti, Infection Prevention